Carrier Screening Market Size, Scope, Revenue Report 2026 to 2035
Market Segmentation:
Carrier Screening Market by Medical Conditions -
• Spinal Muscular Atrophy
• Cystic Fibrosis
• Tay-Sachs
• Gaucher Disease
• Sickle Cell Disease
• Others

Carrier Screening Market by Type -
• Expanded Carrier Screening
• Targeted Disease Carrier Screening
Carrier Screening Market by Technology -
• DNA Sequencing
• Polymerase Chain Reaction
• Microarrays
• Other Technologies (MLPA, Genotyping, Enzyme Screening)
Carrier Screening Market by End Use-
• Hospitals
• Laboratories
• Physician Offices & Clinics
• Other End Users
Carrier Screening Market by Region-
North America-
• The US
• Canada
• Mexico
Europe-
• Germany
• The UK
• France
• Italy
• Spain
• Rest of Europe
Asia-Pacific-
• China
• Japan
• India
• South Korea
• South East Asia
• Rest of Asia Pacific
Latin America-
• Brazil
• Argentina
• Rest of Latin America
Middle East & Africa-
• GCC Countries
• South Africa
• Rest of Middle East and Africa
Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Carrier Screening Market Snapshot
Chapter 4. Global Carrier Screening Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Market Drivers
4.3. Market Challenges
4.4. Market Trends
4.5. Regulatory Landscape
4.6. Reimbursement Analysis
4.7. Porter’s Five Forces Analysis
4.8. Incremental Opportunity Analysis (US$ Mn), 2025–2035
4.9. Market Penetration & Growth Prospect Mapping (US$ Mn), 2026–2035
4.10. Competitive Landscape & Market Share Analysis, 2026
4.11. Impact of Next-Generation Sequencing on Carrier Screening
Chapter 5. Market Segmentation 1: By Medical Conditions
5.1. Market Share, 2025 & 2035
5.2. Market Size (US$ Mn), 2022–2035
5.2.1. Spinal Muscular Atrophy
5.2.2. Cystic Fibrosis
5.2.3. Tay-Sachs
5.2.4. Gaucher Disease
5.2.5. Sickle Cell Disease
5.2.6. Others
Chapter 6. Market Segmentation 2: By Type
6.1. Market Share, 2025 & 2035
6.2. Market Size (US$ Mn), 2022–2035
6.2.1. Expanded Carrier Screening
6.2.2. Targeted Disease Carrier Screening
Chapter 7. Market Segmentation 3: By Technology
7.1. Market Share, 2025 & 2035
7.2. Market Size (US$ Mn), 2022–2035
7.2.1. DNA Sequencing
7.2.2. Polymerase Chain Reaction (PCR)
7.2.3. Microarrays
7.2.4. Other Technologies (MLPA, Genotyping, Enzyme Screening)
Chapter 8. Market Segmentation 4: By End Use
8.1. Market Share, 2025 & 2035
8.2. Market Size (US$ Mn), 2022–2035
8.2.1. Hospitals
8.2.2. Laboratories
8.2.3. Physician Offices & Clinics
8.2.4. Other End Users
Chapter 9. Regional Market Estimates & Trend Analysis
9.1. Global Market Regional Snapshot, 2025 & 2035
9.2. North America
9.2.1. Market Revenue by Country (U.S., Canada, Mexico), 2022–2035
9.2.2. North America Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.2.3. North America Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.2.4. North America Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.2.5. North America Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035
9.3. Europe
9.3.1. Market Revenue by Country, 2022–2035
9.3.2. Europe Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.3.3. Europe Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.3.4. Europe Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.3.5. Europe Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035
9.4. Asia Pacific
9.4.1. Market Revenue by Country, 2022–2035
9.4.2. Asia Pacific Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.4.3. Asia Pacific Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.4.4. Asia Pacific Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.4.5. Asia Pacific Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035
9.5. Latin America
9.5.1. Market Revenue by Country, 2022–2035
9.5.2. Latin America Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.5.3. Latin America Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.5.4. Latin America Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.5.5. Latin America Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035
9.6. Middle East & Africa
9.6.1. Market Revenue by Country, 2022–2035
9.6.2. Middle East & Africa Carrier Screening Market Revenue (US$ Mn) By Medical Conditions, 2022–2035
9.6.3. Middle East & Africa Carrier Screening Market Revenue (US$ Mn) By Type, 2022–2035
9.6.4. Middle East & Africa Carrier Screening Market Revenue (US$ Mn) By Technology, 2022–2035
9.6.5. Middle East & Africa Carrier Screening Market Revenue (US$ Mn) By End Use, 2022–2035
Chapter 10. Competitive Landscape
10.1. Key Strategic Developments (Mergers & Acquisitions, Partnerships, Product Launches)
10.2. Market Share Analysis, 2026
10.3. Company Profiles (10 Players)
10.3.1. Myriad Genetics, Inc.
10.3.2. Natera, Inc.
10.3.3. Laboratory Corporation of America Holdings / Labcorp
10.3.4. Quest Diagnostics Incorporated
10.3.5. BGI Genomics Co., Ltd.
10.3.6. CENTOGENE GmbH
10.3.7. MedGenome Labs Ltd.
10.3.8. GeneDx
10.3.9. Fulgent Genetics, Inc.
10.3.10. Thermo Fisher Scientific Inc.
10.3.11. Illumina, Inc.
10.3.12. CooperSurgical / CooperGenomics
10.3.13. Invitae / Labcorp
10.3.14. Otogenetics Corporation
10.3.15. ATS GeneTech Pvt. Ltd.
10.3.16. Other Emerging Players
Research Design and Approach
This study employed a multi-step, mixed-method research approach that integrates:
- Secondary research
- Primary research
- Data triangulation
- Hybrid top-down and bottom-up modelling
- Forecasting and scenario analysis
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary Research
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Sources Consulted
Secondary data for the market study was gathered from multiple credible sources, including:
- Government databases, regulatory bodies, and public institutions
- International organizations (WHO, OECD, IMF, World Bank, etc.)
- Commercial and paid databases
- Industry associations, trade publications, and technical journals
- Company annual reports, investor presentations, press releases, and SEC filings
- Academic research papers, patents, and scientific literature
- Previous market research publications and syndicated reports
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary Research
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Stakeholders Interviewed
Primary interviews for this study involved:
- Manufacturers and suppliers in the market value chain
- Distributors, channel partners, and integrators
- End-users / customers (e.g., hospitals, labs, enterprises, consumers, etc., depending on the market)
- Industry experts, technology specialists, consultants, and regulatory professionals
- Senior executives (CEOs, CTOs, VPs, Directors) and product managers
Interview Process
Interviews were conducted via:
- Structured and semi-structured questionnaires
- Telephonic and video interactions
- Email correspondences
- Expert consultation sessions
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
Data Processing, Normalization, and Validation
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
- Standardization of units (currency conversions, volume units, inflation adjustments)
- Cross-verification of data points across multiple secondary sources
- Normalization of inconsistent datasets
- Identification and resolution of data gaps
- Outlier detection and removal through algorithmic and manual checks
- Plausibility and coherence checks across segments and geographies
This ensured that the dataset used for modelling was clean, robust, and reliable.
Market Size Estimation and Data Triangulation
Bottom-Up Approach
The bottom-up approach involved aggregating segment-level data, such as:
- Company revenues
- Product-level sales
- Installed base/usage volumes
- Adoption and penetration rates
- Pricing analysis
This method was primarily used when detailed micro-level market data were available.
Top-Down Approach
The top-down approach used macro-level indicators:
- Parent market benchmarks
- Global/regional industry trends
- Economic indicators (GDP, demographics, spending patterns)
- Penetration and usage ratios
This approach was used for segments where granular data were limited or inconsistent.
Hybrid Triangulation Approach
To ensure accuracy, a triangulated hybrid model was used. This included:
- Reconciling top-down and bottom-up estimates
- Cross-checking revenues, volumes, and pricing assumptions
- Incorporating expert insights to validate segment splits and adoption rates
This multi-angle validation yielded the final market size.
Forecasting Framework and Scenario Modelling
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Forecasting Methods
- Time-series modelling
- S-curve and diffusion models (for emerging technologies)
- Driver-based forecasting (GDP, disposable income, adoption rates, regulatory changes)
- Price elasticity models
- Market maturity and lifecycle-based projections
Scenario Analysis
Given inherent uncertainties, three scenarios were constructed:
- Base-Case Scenario: Expected trajectory under current conditions
- Optimistic Scenario: High adoption, favourable regulation, strong economic tailwinds
- Conservative Scenario: Slow adoption, regulatory delays, economic constraints
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.
Request Customization
Add countries, segments, company profiles, or extend forecast — free 10% customization with purchase.
Customize This Report →Enquire Before Buying
Speak with our analyst team about scope, methodology, pricing, or deliverable formats.
Enquire Now →Frequently Asked Questions
Carrier Screening Market Size is valued at USD 1.49 Bn in 2025 and is predicted to reach USD 5.16 Bn by the year 2035
Carrier Screening Market is likely to grow with at a 13.4% CAGR during the forecast period for 2026 to 2035.
Myriad Genetics, Inc., BGI Genomics, Illumina, Inc., Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd, Laboratory Corporation of America Holdings (LabCorp), Otogenetics Corporation, MedGenome, GeneTech (ATS Genetech Pvt Ltd), CENTOGENE GmbH
Carrier Screening Market is segmented into Medical Conditions, Type, Technology, End-Use and By Region
North America region is leading the Carrier Screening Market.